Nitisinone tablets
Form: Tablets
Strength: 2 mg and 5 mg
Reference Brands: Orfadin®
Category: Orphan Drugs
Nitisinone inhibits the enzyme 4-hydroxyphenylpyruvate dioxygenase, reducing the production of toxic metabolites in hereditary tyrosinemia type 1 (HT-1). Benefits include preventing liver and kidney damage, decreasing hypersensitivity reactions, and improving survival rates in HT-1 patients by controlling disease progression.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Galsulfase IV
Strength: 1mg/ml
Form: Lyophilized powder for IV
Reference Brands: Vimizim®(US & EU)
View Details Get Enquiry
Alglucosidase Alfa IV
Strength: 50 mg/vial
Form: Lyophilized powder
Reference Brands: Lumizyme®(US & EU)
View Details Get Enquiry
Treprostinil IV or SC
Strength: 2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)
Form: SC or Intravenous (IV)
Reference Brands: Remodulin®(US & EU)
View Details Get Enquiry
Iloprost inahalation Solution
Strength: 10 mcg/mL
Form: Inhalation Solution (Nebulizer)
Reference Brands: Ventavis®(EU & US)
View Details Get Enquiry